Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Robert G. Bianchi who wrote (986)	7/16/2000 12:34:39 PM
From: Madharry	Read Replies (1) \| Respond to of 1298

Please do your own dilligence. You cannot rely on yahoo or posters for accurate information. I believe CEGE is an excellent buy but the amount of cash and short term investments according to the 10 Q as of 3/31 was $250MM not $350MM. The 10Q is about as accurate as it is going to get as these are documents filed with the SEC. The last time I reviewed the number CEGE net of cash and its investment was around $2 a share which is cheap enough for me.